{"id":58283,"date":"2026-02-06T08:38:24","date_gmt":"2026-02-06T12:38:24","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/corporate-earnings-highlight-q4-and-q3-results-geopolitical-and-macroeconomic-factors-monitored\/58283\/"},"modified":"2026-02-06T08:38:24","modified_gmt":"2026-02-06T12:38:24","slug":"corporate-earnings-highlight-q4-and-q3-results-geopolitical-and-macroeconomic-factors-monitored","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/corporate-earnings-highlight-q4-and-q3-results-geopolitical-and-macroeconomic-factors-monitored\/58283\/","title":{"rendered":"Corporate Earnings Highlight Q4 and Q3 Results; Geopolitical and Macroeconomic Factors Monitored"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Philip Morris International (<a href=\"\/stock\/PM\">PM<\/a>)<\/strong> reported a strong <strong>Q4 adjusted EPS of $7.54<\/strong>, significantly surpassing the estimated $1.70, but announced <em>no share repurchases in 2026<\/em>.<\/li>\n<li><strong>Under Armour (<a href=\"\/stock\/UAA\">UAA<\/a>, <a href=\"\/stock\/UA\">UA<\/a>)<\/strong> posted a <strong>Q3 net loss of $431 million<\/strong> with an <strong>EPS of -$1.01<\/strong>, though its <em>adjusted EPS of $0.09 beat analyst estimates of -$0.02<\/em>.<\/li>\n<li><strong>China<\/strong> has approved <em>some rare earth exports to Japan<\/em>, a development that could ease tensions in critical mineral supply chains.<\/li>\n<li>The <strong>Euro&#39;s strength<\/strong> has drawn attention from the <strong>European Central Bank (ECB)<\/strong>, raising <em>concerns about currency-driven disinflation<\/em> and its potential impact on the <strong>EURUSD<\/strong> exchange rate.<\/li>\n<li><strong>Pfizer (<a href=\"\/stock\/PFE\">PFE<\/a>)<\/strong> awaits an <strong>FDA PDUFA action date for HYMPAVZI in Q2 2026<\/strong>.<\/li>\n<\/ul>\n<h2>Corporate Earnings: Philip Morris and Under Armour Report<\/h2>\n<p><strong>Philip Morris International (<a href=\"\/stock\/PM\">PM<\/a>)<\/strong> delivered robust <strong>Q4 2025 adjusted earnings per share (EPS) of $7.54<\/strong>, significantly exceeding the analyst estimate of $1.70. The tobacco giant also reported <strong>Q4 revenue of $10.4 million<\/strong>, falling short of the estimated $10,440 million. Looking ahead, the company forecasts <strong>full-year adjusted EPS for FY 2026 to be between $8.38 and $8.53<\/strong> and anticipates <strong>first-quarter adjusted diluted EPS of $1.80 to $1.85<\/strong>. Notably, Philip Morris stated it <em>sees no share repurchases in 2026<\/em>, a decision that may impact investor sentiment regarding capital allocation. The company declared a <strong>Q4 dividend of $1.47<\/strong>.<\/p>\n<p><strong>Under Armour (<a href=\"\/stock\/UAA\">UAA<\/a>, <a href=\"\/stock\/UA\">UA<\/a>)<\/strong> released its <strong>Q3 2026 results<\/strong>, revealing a <strong>gross margin of 44.4%<\/strong>. The athletic apparel and footwear company reported a <strong>net loss of $431 million<\/strong>, translating to an <strong>EPS of -$1.01<\/strong>. Despite the significant net loss, Under Armour&#39;s <em>adjusted net income stood at $37 million<\/em>, with an <strong>adjusted EPS of $0.09<\/strong>, which surpassed the estimated -$0.02. The company&#39;s <strong>Q3 EBIT was -$150 million<\/strong>.<\/p>\n<h2>Global Trade and Macroeconomic Shifts<\/h2>\n<p>In a significant development for global supply chains, <strong>China<\/strong> has approved <em>some rare earth exports to Japan<\/em>. This move comes amidst ongoing efforts by Japan to reduce its reliance on Chinese rare earth supplies and diversify its critical mineral sources. The decision could be interpreted as a step towards easing trade tensions in this strategically important sector.<\/p>\n<p>Meanwhile, the <strong>Euro&#39;s strength<\/strong> has become a focal point for the <strong>European Central Bank (ECB)<\/strong>. The trade-weighted euro is currently at <em>multi-decade highs<\/em>, prompting questions about how long the ECB can overlook <em>currency-driven disinflation<\/em>. Any indication that inflation risks are trending lower due to a strong euro could potentially <em>weigh on the EURUSD exchange rate<\/em>.<\/p>\n<h2>Pharmaceutical Sector Update<\/h2>\n<p><strong>Pfizer (<a href=\"\/stock\/PFE\">PFE<\/a>)<\/strong> announced that the <strong>U.S. Food and Drug Administration (FDA)<\/strong> has set a <strong>PDUFA (Prescription Drug User Fee Act) action date for HYMPAVZI in Q2 2026<\/strong>. This regulatory milestone is crucial for the potential approval and market availability of the drug, which is being evaluated for hemophilia A or B.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Philip Morris International (PM) reported a strong Q4 adjusted EPS of $7.54, significantly surpassing the estimated $1.70, but [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5833,34,6034,1807,6395,3798,16870,3886,16879,4037,4271,4472,5191,5555],"class_list":["post-58283","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-fda","tag-pfe","tag-euro","tag-earnings","tag-philip-morris","tag-pm","tag-ua","tag-eps","tag-under-armour","tag-ecb","tag-uaa","tag-global-economy","tag-rare-earths","tag-pfizer"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=58283"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58283\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=58283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=58283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=58283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}